My MS My Way was developed by the MS Technology Collaborative, a landmark alliance of organizations passionate about helping people with multiple sclerosis (MS) maximize their abilities. The alliance brings together leaders from the pharmaceutical, technology, and patient advocacy sectors, including Bayer HealthCare Pharmaceuticals, a U.S. affiliate of Bayer Schering Pharma AG, Germany; Microsoft's Accessibility Business Unit; and the National Multiple Sclerosis Society. Each organization has a specialized understanding of the needs of people with MS.

In addition, a project Steering Committee comprised of people with MS from across the country oversees the program. They help to ensure the outcomes from the project truly address the unmet needs of people living with MS.

Microsoft brings its technology expertise to the MS Technology Collaborative. For nearly twenty years, Microsoft, a global technology leader, has focused on developing accessible technology for everyone, including those with disabilities.

Bayer HealthCare Pharmaceuticals is a company that has been at the forefront of MS therapy development, starting with the introduction of the very first therapy for relapsing remitting MS and continuing with its innovative treatments in development today.

The National Multiple Sclerosis Society, the world's largest MS research, service, and advocacy organization, is dedicated to achieving a world free of MS. The Society will field the MS Technology Collaborative survey to a significant number of people living with MS, to help ensure that as many people with MS have the opportunity to participate and provide feedback.